Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 1:41 PM UTC
| NCT Number | NCT03290534 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | CivaTech Oncology |
| Last Updated on CT.gov | April 4, 2025 (Apr 4, 2025) |
As of July 18, 2026: Clinical trial NCT03290534 is currently recruiting participants. This phase2 study for lung cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by CivaTech Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03290534 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03290534 was last updated Apr 4, 2025 (April 4, 2025). HelloStudys verifies this status automatically.